ProCyte Corporation (OTCBB:PRCY) is a publicly-held healthcare company that is committed to bringing innovation and experience to skin health, hair care and cosmetic surgery. In addition to developing its own products the company offers contract manufacturing services to biotech and pharmaceutical companies.

ProCyte holds over 100 issued patents and patent registrations worldwide on its proprietary copper-based technology.

ProCyte's copper peptide technology utilizes a sequence of amino acid carriers for essential copper. This unique delivery system mimics the body's natural copper transport mechanisms.

ProCyte's polymer technology for wound care applications, including dressings, for diabetic ulcers, venous stasis ulcers, pressure sores, liposuction and plastic surgery.

Located in Redmond, Washington, the Company's scientific team continues its pursuit of new technology and excellence, quickly bringing new products to the marketplace that address healthcare and physician needs.

Healing the Wounds of Time, Neova, Tricomin, GraftCyte, Complex Cu3, TiSilc, Iamin and Osmocyte are all registered trademarks of ProCyte Corp.